| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Product revenue, net | |||||||||
34,921 | 23,376 | - | - | - | - | - | - | - | - |
Product revenue, net | |||||||||
- | - | 15,520 | - | - | - | - | - | - | - |
Product revenue, net | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Revenue - related party | |||||||||
1,708 | 3,506 | 1,725 | - | - | - | 0 | - | - | - |
Net revenue | |||||||||
36,629 | 26,882 | 17,245 | 16,480 | 863 | - | - | - | - | - |
Net revenue | |||||||||
- | - | - | 16,480 | 863 | 0 | 0 | - | - | - |
Operating expenses | |||||||||
Cost of goods sold - product revenue | |||||||||
10,532 | 6,125 | 3,658 | - | - | - | - | - | - | - |
Research and development | |||||||||
75,236 | 83,333 | - | - | - | - | - | - | - | - |
Research and development - licenses acquired | |||||||||
6,090 | 4,050 | - | - | - | - | - | - | - | - |
General and administrative | |||||||||
55,590 | 53,371 | - | - | - | - | - | - | - | - |
Total operating expenses | |||||||||
147,448 | 146,879 | - | - | - | - | - | - | - | - |
Cost of goods sold - product revenue | |||||||||
- | - | - | 790 | 0 | - | - | - | - | - |
Research and development | |||||||||
- | - | 48,322 | 35,134 | 29,810 | - | 25,682 | 17,468 | 8,583 | 8,341 |
Research and development - licenses acquired | |||||||||
- | - | 4,164 | 5,532 | 11,408 | 0 | 0 | 1,043 | 20,706 | - |
General and administrative | |||||||||
- | - | 50,897 | 28,229 | 18,734 | - | 10,098 | 8,665 | 5,755 | 900 |
Total operating expenses | |||||||||
- | - | 107,041 | 82,190 | 51,394 | 20,652 | 35,780 | - | - | - |
Loss from operations | |||||||||
-110,819 | -119,997 | -89,796 | -65,710 | -50,531 | -20,652 | -35,780 | -27,176 | -35,044 | -9,241 |
Other income (expense) | |||||||||
Interest income | |||||||||
2,559 | 1,104 | 819 | 298 | 245 | 662 | 545 | 236 | 165 | 61 |
Interest expense and financing fee | |||||||||
11,849 | 10,340 | 7,687 | 3,690 | 1,484 | 1,338 | - | - | - | - |
Interest expense and financing fee | |||||||||
11,849 | 10,340 | 7,687 | 3,690 | 1,484 | - | - | - | - | - |
Interest expense | |||||||||
- | - | - | - | - | - | 1,923 | - | - | - |
Change in fair value of derivative liability | |||||||||
27 | 682 | 368 | 1,039 | 438 | 0 | 0 | - | - | - |
Change in fair value of subsidiary convertible note | |||||||||
0 | 437 | -457 | -78 | 0 | 0 | - | - | - | - |
Change in fair value of subsidiary convertible note | |||||||||
0 | 437 | -457 | -78 | 0 | - | - | - | - | - |
Interest expense | |||||||||
- | - | - | - | - | - | - | 670 | 74 | 1,535 |
Change in fair value of investments | |||||||||
0 | -1,390 | 226 | -1,071 | -1,675 | 942 | 0 | 0 | - | - |
Gain on deconsolidation of Caelum | |||||||||
18,476 | 0 | - | - | - | - | - | - | - | - |
Other income | |||||||||
0 | 68 | -250 | 0 | 0 | - | - | - | - | - |
Other income | |||||||||
- | - | - | - | - | - | - | - | 0 | 733 |
Total other income (expense) | |||||||||
9,159 | -10,803 | -7,717 | -5,580 | -3,352 | 266 | -1,378 | - | - | - |
Loss from continuing operations | |||||||||
-101,660 | -130,800 | -97,513 | -71,290 | -53,883 | - | - | - | - | - |
Discontinued operations: | |||||||||
Gain from disposal of National | |||||||||
0 | 2,333 | 0 | - | - | - | - | - | - | - |
Loss from discontinued operations, net of tax | |||||||||
0 | -13,469 | -2,323 | - | - | - | - | - | - | - |
Total loss from discontinued operations | |||||||||
0 | -11,136 | -2,323 | - | - | - | - | - | - | - |
Income tax expense | |||||||||
- | - | - | 0 | 0 | - | - | - | - | - |
Net loss | |||||||||
-101,660 | -141,936 | -99,836 | -71,290 | -53,883 | -20,386 | -37,158 | - | - | - |
Less: net loss attributable to non-controlling interests | |||||||||
-61,700 | -57,789 | -32,960 | -16,195 | -5,455 | 0 | 0 | - | - | - |
Warrant expense | |||||||||
- | - | - | - | - | - | - | - | 1,407 | - |
Net income (loss) attributable to common stockholders | |||||||||
-39,960 | -84,147 | -66,876 | -55,095 | -48,428 | -20,386 | -37,158 | -27,610 | -36,360 | -9,982 |
Loss from continuing operations per common share - basic and diluted | |||||||||
-1.86 | -3.01 | -2.34 | - | - | - | - | - | - | - |
Loss from discontinued operations per common share - basic and diluted | |||||||||
0.00 | -0.26 | -0.06 | - | - | - | - | - | - | - |
Common Stock dividend to Series A Convertible Preferred Stockholders | |||||||||
- | - | - | - | - | - | - | - | -5,861 | - |
Net loss attributed to Common Stockholders | |||||||||
- | - | - | - | - | - | - | - | -42,221 | -9,982 |
Net loss per common share attributable to common stockholders - basic and diluted | |||||||||
-0.73 | -1.94 | -1.61 | -1.38 | -1.24 | -0.56 | -1.22 | -1.27 | -5.51 | -2.24 |
Weighted average common shares outstanding - basic and diluted | |||||||||
54,711 | 43,461 | 41,658 | 39,962 | 39,146 | 36,323 | 30,429 | 21,654 | 7,662 | 4,453 |